Variability of HIV infections.
暂无分享,去创建一个
[1] M. Nowak. HIV mutation rate , 1990, Nature.
[2] A. Dalgleish,et al. Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. , 1988, Virology.
[3] M. Ascher,et al. The initial immune response to HIV and immune system activation determine the outcome of HIV disease. , 1991, Journal of acquired immune deficiency syndromes.
[4] A. Phillips,et al. Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort. , 1989, AIDS.
[5] P. Fultz,et al. Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). , 1989, AIDS research and human retroviruses.
[6] J. Berzofsky,et al. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. , 1989, Journal of immunology.
[7] T. H. Lee,et al. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120 , 1989, Journal of virology.
[8] D. Ho,et al. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.
[9] A. Dalgleish,et al. Variable and conserved neutralization antigens of human immunodeficiency virus , 1986, Nature.
[10] H. Vinters,et al. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. , 1987, Science.
[11] J. Clements,et al. Genomic changes associated with antigenic variation of visna virus durig persistent infection. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[12] H. Whittle,et al. Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia , 1990, Journal of virology.
[13] J. Mullins,et al. Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 , 1990, Nature.
[14] L. Pearl,et al. Characterization of HIV‐1 neutralization escape mutants , 1989, AIDS.
[15] M A Nowak,et al. Models of interactions between HIV and other pathogens. , 1992, Journal of theoretical biology.
[16] C. Cheng‐Mayer,et al. Biologic features of HIV-1 that correlate with virulence in the host. , 1988, Science.
[17] L. Loeb,et al. Fidelity of HIV-1 reverse transcriptase. , 1988, Science.
[18] L. Arthur,et al. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[19] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[20] J. Berzofsky,et al. A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. , 1989, Science.
[21] G. Shaw,et al. Extensive variation of human immunodeficiency virus type-1 in vivo , 1988, Nature.
[22] M A Nowak,et al. Mathematical biology of HIV infections: antigenic variation and diversity threshold. , 1991, Mathematical biosciences.
[23] V. Favier,et al. Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Davide,et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.
[25] P. Simmonds,et al. Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source , 2022 .
[26] David Looney,et al. Biologically diverse molecular variants within a single HIV-1 isolate , 1988, Nature.
[27] Andreas Meyerhans,et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations , 1989, Cell.
[28] T. Kirkwood,et al. A model of human immunodeficiency virus infection in T helper cell clones. , 1990, Journal of theoretical biology.
[29] R. Redfield,et al. Type-restricted neutralization of molecular clones of human immunodeficiency virus. , 1988, Science.
[30] J. Goudsmit. Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts. , 1988, AIDS (London).
[31] J. Berzofsky,et al. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. , 1991, Journal of immunology.
[32] K Bebenek,et al. The accuracy of reverse transcriptase from HIV-1. , 1988, Science.
[33] A. Profy,et al. Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1 , 1990, Science.
[34] C. Debouck,et al. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Ellis,et al. Antigenic variation of caprine arthritis-encephalitis virus during persistent infection of goats. , 1987, The Journal of general virology.
[36] R. Redfield,et al. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. , 1986, Science.
[37] P Balfe,et al. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1 , 1990 .
[38] S. Wain-Hobson. HIV genome variability in vivo , 1989, AIDS.
[39] M A Nowak,et al. The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. , 1990, AIDS.
[40] C. Kuiken,et al. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. , 1991, Virology.
[41] M. Reitz,et al. In vitro generation of an HTLV-III variant by neutralizing antibody. , 1986, Journal of immunology.
[42] Robin A. Weiss,et al. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients , 1985, Nature.
[43] C H Fox,et al. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. , 1989, Science.
[44] M A Nowak,et al. Antigenic diversity thresholds and the development of AIDS. , 1991, Science.
[45] A. Collier,et al. Plasma viremia in human immunodeficiency virus infection. , 1989, The New England journal of medicine.
[46] E. Werner,et al. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. , 1988, Immunology today.
[47] M. Robert-Guroff,et al. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex , 1985, Nature.
[48] D. Cooper,et al. Primary HIV infection: host responses and intervention strategies. , 1991, AIDS.
[49] C. Issel,et al. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection , 1986, Journal of virology.
[50] J. Goedert,et al. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. , 1987, Annals of internal medicine.
[51] J. Goudsmit,et al. Appearance of predictors of disease progression in relation to the development of AIDS , 1989, AIDS.